Presentation TCT 2017 Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials Presenter: Bernard J. Gersh, Michel Ovize October 31, 2017
Presentation TCT 2017 CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles October 31, 2017
Presentation TCT 2017 First of the Class: Tissue Engineering Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent October 31, 2017
Presentation TCT 2017 New Strategies for a Chronic Scenario: Combinative Approaches Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel October 31, 2017
Presentation TCT 2017 New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry October 31, 2017
Presentation TCT 2017 New Targets: Heart Failure With Preserved Ejection Fraction Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani October 31, 2017
Presentation TCT 2017 In Which Direction is Cell Based Heart Failure Therapy Headed? Presenter: Francisco Fdez-Aviles, Emerson C. Perin October 31, 2017
Presentation TCT 2017 TCT 32: Why Does Exercise in Cold Air Increase Susceptibility to Myocardial Ischaemia? Presenter: Justin E. Davies, Bernard De Bruyne, Rupert Williams, MD October 31, 2017
Presentation TCT 2017 TCT 69: Comparison of Quantitative Flow Ratio and Fractional Flow Reserve to Identify Myocardial Ischemia: Validation With Myocardial Perfusion Scintigraphy and Cardiovascular Magnetic Resonance Presenter: Nick Curzen, William F. Fearon, Jelmer Westra October 31, 2017
Presentation TCT 2017 Trials With Cardiac Derived Cells: CAREMI and ALLSTAR Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz October 31, 2017
Presentation TCT 2017 TCT 79: What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial Presenter: Davide Capodanno, Tullio Palmerini, Shmuel Chen, MD October 31, 2017
Presentation TCT 2017 TCT 71: Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Non-target Vascular Territories in a Porcine Microvascular Injury Model Presenter: Nick Curzen, William F. Fearon, Joo Myung Lee October 31, 2017
Presentation TCT 2017 US Trial Background and Update: Preserve-AMI Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry October 31, 2017
Presentation TCT 2017 The Clinical Point of View: Is There an AMI Need for Cell Therapy? Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez October 31, 2017
Presentation TCT 2017 TCT 2: Coronary Angiographic Findings and Outcomes in Patients With Sudden Cardiac Arrest Without ST-Elevation Myocardial Infarction - A SWEDEHEART Study Presenter: Rajesh M. Dave, A. Michael Lincoff, Sasha Koul, MD October 31, 2017
Presentation TCT 2017 TCT 97: Culprit Lesion vs Multi-Vessel Intervention in Patients With Cardiogenic Shock Complicating Myocardial Infarction: Incidence and Outcomes From the London Heart Attack Group Presenter: Vladimir Dzavik, Srihari S. Naidu, Krishnaraj Rathod, MD October 31, 2017
Presentation TCT 2017 TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD October 31, 2017
Presentation TCT 2017 TCT 1: Direct Stenting Strategy Is Associated With Improved Outcomes in Patients With Totally Occluded Culprit Arteries Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction Presenter: Rajesh M. Dave, A. Michael Lincoff, Ivan Bessonov, MD October 31, 2017
Presentation TCT 2017 CASE 2- Image Guided Intervention in Traumatic Dissection of Dominant Right Coronary Artery Presenting as Acute Myocardial Infarction Presenter: Pedro de Araujo Goncalves, Rabin dra Nath Chakraborty October 30, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017